{
    "2021-01-05": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：国药中生新冠疫苗获批上市 重申看好生物制品中长期投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "国药中生",
                        "新冠疫苗",
                        "获批上市",
                        "中长期投资机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年11月疫苗批签发数据跟踪报告：行业高景气，重点公司表现亮眼，维持“强于大市”评级",
                "features": {
                    "keywords": [
                        "医药行业",
                        "疫苗",
                        "批签发",
                        "高景气",
                        "重点公司",
                        "强于大市"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}